According to the latest report by IMARC Group, titled “Brachytherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on brachytherapy industry size. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global brachytherapy market size reached US$ 856.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,195.9 Million by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.
Brachytherapy, a form of radiotherapy, is a medical technique when radioactive sources are inserted. close to or inside the tumor. It delivers high doses of radiation to destroy cancer cells while reducing the amount of exposure to nearby healthy tissues. It is categorized into two main types: low-dose rate (LDR) and high-dose rate (HDR) brachytherapy, with applications ranging from prostate cancer to breast, skin, cervical, and other types of cancer. This treatment method offers several advantages, including targeted therapy with fewer treatment sessions, reduced radiation exposure to healthy tissues, and the possibility of combining with other treatment modalities for enhanced efficacy. The precision, effectiveness, and convenience of brachytherapy make it a valuable option in cancer treatment, contributing to its adoption in oncology centers worldwide.
Get a Sample Copy of this Report: https://www.imarcgroup.com/brachytherapy-market/requestsample
Market Trends:
The global market is majorly propelled by the rising incidence of cancer and the increasing recognition of brachytherapy's benefits in cancer treatment. Along with this, technological advancements in brachytherapy equipment and techniques, such as the development of image-guided brachytherapy (IGBT), are improving treatment precision and patient outcomes, further driving market expansion. In addition, the escalating preference for minimally invasive procedures among patients and healthcare providers alike is bolstering the demand for brachytherapy. Moreover, the expansion of healthcare infrastructure across emerging economies and the rising investments in cancer research are contributing to the market's growth. Apart from this, government initiatives promoting cancer awareness and screening programs are also pivotal in diagnosing cancers at stages where brachytherapy can be most effective. Furthermore, collaborations between medical institutions for research and development activities in oncology are creating a positive market outlook.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/brachytherapy-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Acusis
- Transcend Services
- Naunce Communications
- MModal
- iMedX Information Services
- Global Medical Transcription
- nThrive
- MTBC
- Medi-Script Plus
- Transtech Medical Solutions
Brachytherapy Market Segmentation:
Our report has categorized the market based on region, service type, technology, mode of procurement and end user.
Breakup by Service Type:
- History and Physical Report
- Discharge Summary
- Operative Note or Report
- Consultation Report
- Others (Pathology Report, Radiology Report, etc.)
Breakup by Technology:
- EMR/EHR
- PACS
- RIS
- SRT
- Others
Breakup by Mode of Procurement:
- Outsourcing
- Offshoring
- Both
Breakup by End User:
- Hospitals
- Clinics
- Clinical Laboratories
- Academic Medical Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comments